ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 184 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 6 | -92.4% | 0.00% | – |
| Q1 2020 | $4,000 | +33.3% | 79 | +41.1% | 0.00% | – |
| Q3 2019 | $3,000 | -40.0% | 56 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -50.0% | 56 | -44.0% | 0.00% | – |
| Q1 2019 | $10,000 | -69.7% | 100 | -74.2% | 0.00% | – |
| Q3 2018 | $33,000 | -84.1% | 387 | -78.5% | 0.00% | -100.0% |
| Q2 2018 | $208,000 | +3366.7% | 1,798 | +1698.0% | 0.00% | – |
| Q4 2017 | $6,000 | -82.9% | 100 | -87.1% | 0.00% | – |
| Q2 2015 | $35,000 | +45.8% | 778 | 0.0% | 0.00% | – |
| Q1 2015 | $24,000 | +300.0% | 778 | +380.2% | 0.00% | – |
| Q3 2014 | $6,000 | +100.0% | 162 | +161.3% | 0.00% | – |
| Q2 2014 | $3,000 | +200.0% | 62 | +181.8% | 0.00% | – |
| Q1 2014 | $1,000 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,546,097 | $66,590,000 | 9.91% |
| RA Capital Management | 1,539,586 | $66,310,000 | 6.70% |
| SENZAR ASSET MANAGEMENT, LLC | 255,128 | $10,988,000 | 4.20% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 158,315 | $6,819,000 | 1.56% |
| Sarissa Capital Management LP | 105,000 | $4,522,000 | 1.54% |
| Ghost Tree Capital, LLC | 50,000 | $2,154,000 | 1.52% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 118,445 | $5,102,000 | 0.90% |
| WALL STREET ASSOCIATES | 219,200 | $9,441,000 | 0.81% |
| Granite Point Capital Management, L.P. | 25,000 | $1,077,000 | 0.74% |
| BAILARD, INC. | 91,500 | $3,941,000 | 0.61% |